Efficacy, safety, and treatment patterns of ruxolitinib 1.5% cream in adult atopic dermatitis: A single center retrospective study

Nicole S. Stefanko, Victor L. Quan, Raj Chovatiya*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)415-417
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume89
Issue number2
DOIs
StatePublished - Aug 2023

Keywords

  • atopic dermatitis
  • eczema
  • ruxolitinib

ASJC Scopus subject areas

  • Dermatology

Cite this